June 18, 2018
2,177,771
31,203
6,623
1.74%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
9:13Now PlayingIn October 2012, Carey Callahan began a course of bimonthly intramuscular testosterone injections. After years of harassment and discomfort in her female body, she had made the decision to transition to being male. In the short term, she was happy. But she soon discovered that life as a transgender man was not what she had expected. Her discomfort persisted, as did the harassment.
Nine months after her first injection, Carey stopped hormone-replacement therapy. A year after that, she made the decision to return to identifying as female. “I regret it,” Carey says of her choice to transition in a new Atlantic documentary.
Recently, Carey began speaking out about her experience, joining a small but vocal group of socalled detransitioners, as profiled in Jesse Singal’s cover story for the July/August issue of The Atlantic. Read it here
Subscribe to The Atlantic on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.